Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided Double Ethanol Lavage for Pancreatic Cysts
NCT02213419Phase 1Unknown
- Sponsor
- Samsung Medical Center
- Start
- Oct 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ethanol in pancreatic cyst and pancreatic mucinous cystic neoplasm (MCN), sponsored by Samsung Medical Center. Primary endpoint: Rate of Subjects with Complete or Partial response of treatment at 1 year. Status: unknown.
02
Drugs
ethanol
03
Conditions
pancreatic cystpancreatic mucinous cystic neoplasm (MCN)
Beyond the preview
Go deeper on NCT02213419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02213419.